期刊文献+

甲状腺功能亢进症患者血浆对氧磷酯酶1活性的测定

Analysis of Paraoxonase 1 Activity in the Patients with Hyperhyroidism
原文传递
导出
摘要 目的:探讨甲状腺功能亢进症(甲亢)患者血浆对氧磷酯酶1(PON1)活性变化以及与其它氧化应激指标的关系。方法:分别测定50名对照组和78例甲亢组空腹血浆中游离三碘甲状腺原氨酸(FT3)、游离甲状腺素(FT4)、促甲状腺激素(TSH)、PON1活性、超氧化物歧化酶(SOD)、丙二醛(MAD)、氧化低密度脂蛋白(ox-LDL)及血脂含量,并进行相关性分析。结果:甲亢患者血浆PON1活性(139±64)kU/L,ox-LDL(598.3±58.6)μg/L,MDA(15.11±3.26)μmol/L及SOD(80.2±25.3)NU/mL。对照组上述指标分别为:PON1(168±70)kU/L,ox-LDL(446.2±62.2)μg/L,MDA(10.02±3.00)μmol/L,SOD(92.9±26.9)NU/mL。血浆PON1和SOD活性显著低于对照组(P<0.01),ox-LDL和MDA水平显著高于对照组(P<0.01)。甲亢患者血浆PON1活性与SOD呈正相关(r=0.381,P<0.05),与ox-LDL、MDA呈负相关(r=-0.411,r=-0.445,P<0.01)。结论:甲亢患者血浆PON1活性显著降低,可能与氧化应激增强有关。 Objective: To understand the PON1 (PON1) activity in the patients with hyperthyroidism, and the relationship between PON1 activity and other oxidative stress parameter. Methods: The fasting plasma levels of free triiodothyronine (FT3), free thyroxin(FT4), thyroid stimulating hormone (TSH), PON1 activity, superoxide dismutase (SOD) and malondialdehyde (MDA), oxidized low-density lipoprotein (ox-LDL) level and lipids levels in 50 normal controls and 78 hyperthyroidism patients were determined respectively. The correlation analysis were completed. Results: In hyperthyroidism patients plasma PON1, ox-LDL, MDA and SOD were ( 139±64) kU/L, (598.3±8.6)μg/ L, (15.11±3.26)μmol/L, (156.4±32.2)U/L, (80.2±25.3)NU/mL,respectively. In the normal control subjects PON1, ox-LDL, MDAand SOD were (168±70)kU/L, (446.2±62.2)μg/L, (10.02±3.00) μmol/L,(92.9±26.9)NU/mL, respectively. The plasma PON1 and SOD activity were significantly lower in hyperthyroidism patients than in the control subjects (P〈0.01). The plasma MDA and ox-LDL levels were significantly higher in hyperthyroidism patients than in the control subjects (P〈0.01). The analysis of linear correlation showed PON1 was positively correlated with SOD(r=0. 381, P〈0.05), and negatively correlated with ox-LDL (r =-0. 411, r =-0. 445, P〈0.01). Conclusion:Plasma PON1 activity was significantly decreased in patients with hyperthyroidism. Increased oxidative stress are associated with decreased PON1 activity in the hyperthyroidism state.
出处 《华西医学》 CAS 2009年第4期902-904,共3页 West China Medical Journal
关键词 甲状腺功能亢进症 对氧磷酯酶1 丙二醛 超氧化物歧化酶 hyperthyroidism paraoxonasel superoxide Dismutase malondialdehyde
  • 相关文献

参考文献12

  • 1COSTANTINI F, PIERDOMENICO S D, CESARE D D, et al. Effect of thyroid function on LDL oxidation [J ]. Arterioscler Thromb Vase Biol, 1998, 18 : 732-737. 被引量:1
  • 2DRRINGTON P N, MACKNESS B, MACKNESS M I. Paraoxonase and therosclerosis[J]. Arterioscler Thromb Vase Biol, 2001, 21: 473-480. 被引量:1
  • 3TSUZURA S, IKEDA Y, SUEHIRO T, et at. Correlation of plasma oxidized low-density lipoprotein levels to vascular complications and human serum paraoxonase in patients with type 2 diabetes[J]. Metabolism, 2004, 53(3) ..297-302. 被引量:1
  • 4MACKNESS M, HARTY D, BHATNAGAR D, et al. Serum paraoxonase activity in familial hypereholesterolemia and insulin-dependent diabetes mellitus[J]. Atherosclerosis, 1991, 86:193-199. 被引量:1
  • 5蒋兴亮,周京国,唐中.脑梗死患者血浆对氧磷酯酶-1和氧化低密度脂蛋白水平的变化及意义[J].中国老年学杂志,2005,25(9):1026-1027. 被引量:6
  • 6FERRE N, CAMPS J, PRATS E, et al. Serum paraoxonase activity: a new additional test for the improved evaluation of chronic liver damage[J]. Clin Chem, 2002, 48(1):261-268. 被引量:1
  • 7PEREIRA B, ROSA LF, SAFI, et al. Control of superoxide dismutase, eatalase and glutathione peroxidase activities in rat lymphoid organs hy thyroid hormones. J Endoerinol, 1994, 140: 73-77. 被引量:1
  • 8RAISZADEH F, SOLATI M, ETEMADI A, etal. Serum paraoxonase activity before and after treatment of thyrotoxicosis[J]. Clinical Endocrinology, 2004, 60: 75-80. 被引量:1
  • 9AZIZI F, RAISZADEH F, SOLATI M, et al. Serum paraoxonase 1 activity is decreased in thyroid dysfuncyion[J].J Endocrinol Invest, 2003, 26:703-709. 被引量:1
  • 10AVIRAM M, ROSENBLAT M, BILLEKE S, etal. Human serum paraoxonase (PON1) is inaetiviated by oxidized low density lipoprotein and preserved by antioxidants[J]. Free Radic Biol Med,1999,26:892-904. 被引量:1

二级参考文献8

  • 1Mackness MI,Durringhton PN. HDL,its enzymes and its potential to influence lipid peroxidation[J]. Atherosclerosis,1995;115:243-53. 被引量:1
  • 2Steinberg D,Parthasarathy S,Carew TE,et al. Beyond cholesterol Modifications of low-density lipoprotein that increase its atherogenicity[J]. New Engl J Med,1989;320:915-24. 被引量:1
  • 3Sanghera DK,Saha SN,Aston CE, et al. Genetic polymorphism of paraoxonase and the risk of coronary heart disease[J]. Arterioscler Thromb Vasc Biol,1997;17:1067-73. 被引量:1
  • 4Ferre N,Camps J,Prats E,et al. Serum paraoxonase activity: a new additional test for the improved evaluation of chronic liver damage[J]. Clin Chem,2002;48(1):261-8. 被引量:1
  • 5Mackness MI,Harty D,Bhatnagar D,et al. Serum paraoxonase activity in familial hypercholesterolemia and insulin-dependent diabetes mellitus[J]. Atherosclerosis,1991;86:193-9. 被引量:1
  • 6Steinberg D. Low density lipoprotein oxidation and its pathobiological significance[J]. J Biol Chem,1997;272:20963-6. 被引量:1
  • 7Aviram M,Rosenblat M,Billeke S,et al. Human serum paraoxonase(PON1) is inactiviated by oxidized low density lipoprotein and preserved by antioxidants[J]. Free Radic Biol Med,1999;26:892-904. 被引量:1
  • 8James RJ,Garin MCB,Calabresi L,et al. Modulated serum activities and concentrations of paraoxonase in high desity lipoprotein deficiency states[J]. Atherosclerosis,1998;139(1):77-82. 被引量:1

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部